Journal Publications
Project Data Sphere's success is ultimately measured by the practice-changing scientific insights discovered by the research community. We are proud to share the following list of peer-accepted publications, and we are grateful to the data providers, research scientists, and patients that make this possible.
| Author(s) |
Date |
Article Title | Journal |
|---|---|---|---|
|
Enrique Vazquez, Henri Gouraud, Florian Naudet, Cary P Gross, Harlan M Krumholz, Joseph S Ross, Joshua D Wallach |
August 2021 | Characteristics of available studies and dissemination of research using major clinical data sharing platforms | Clinical Trials |
|
Olutomilayo Olayemi Petinrin; Xiangtao Li; Ka-Chun Wong |
August 2021 | Particle Swarm Optimized Gaussian Process Classifier for Treatment Discontinuation Prediction in Multicohort Metastatic Castration-Resistant Prostate Cancer Patients | IEEE Journal of Biomedical and Health Informatics |
|
Hirotaka Miyashita, Christina Cruz, Vaibhav Patel |
August 2021 | Risk factors of skeletal-related events in patients with bone metastatic castration-resistant prostate cancer undergoing treatment with zoledronate | Supportive Care in Cancer |
|
Amanda C Guidon, Leeann B Burton, Bart K Chwalisz, James Hillis, Teilo H Schaller, Anthony A Amato, Allison Betof Warner, Priscilla K Brastianos, Tracey A Cho, Stacey L Clardy, Justine V Cohen, Jorg Dietrich, Michael Dougan, Christopher T Doughty, Divyanshu Dubey, Jeffrey M Gelfand, Jeffrey T Guptill, Douglas B Johnson, Vern C Juel, Robert Kadish, Noah Kolb, Nicole R LeBoeuf, Jenny Linnoila, Andrew L Mammen, Maria Martinez-Lage, Meghan J Mooradian, Jarushka Naidoo, Tomas G Neilan, David A Reardon, Krista M Rubin, Bianca D Santomasso, Ryan J Sullivan, Nancy Wang, Karin Woodman, Leyre Zubiri, William C Louv, Kerry L Reynolds |
July 2021 | Consensus disease definitions for neurologic immune-related adverse events of immune checkpoint inhibitors | Journal for ImmunoTherapy of Cancer |
|
Takuma Oda, Shih-Wei Chiu, Takuhiro Yamaguchi |
July 2021 | Semi-automated Conversion of Clinical Trial Legacy Data into CDISC SDTM Standards Format Using Supervised Machine Learning | Methods of Information in Medicine |
|
Aakanksha Khandelwal, Mace Rothenberg, Sean Khozin, Amanda C Guidon, Michael Dougan, Leyre Zubiri, Laura Petrillo, Meghan E Sise, Alexandra-Chloe Villani, Douglas B Johnson, Osama Rahma and Elad Sharon |
July 2021 | Immune-related adverse events associated with immune checkpoint inhibitors: a call to action for collecting and sharing clinical trial and real-world data | Journal for ImmunoTherapy of Cancer |
|
Geoffrey Fell, Robert A Redd, Alyssa M Vanderbeek, Rifaquat Rahman, Bill Louv, Jon McDunn, Andrea Arfè, Brian M Alexander, Steffen Ventz, Lorenzo Trippa |
June 2021 | KMDATA: a curated database of reconstructed individual patient-level data from 153 oncology clinical trials | Database |
|
Mustafa Hashmi , Jeremy Rassen & Sebastian Schneeweiss |
June 2021 | Single-arm oncology trials and the nature of external controls arms | Journal of Comparative Effectiveness Research |
|
Michael J. Kane |
June 2021 | Towards a Grammar for Processing Clinical Trial Data | R Journal Volume |
|
Shalhout, Sophia Z.; Kaufman, Howard L.; Sullivan, Ryan J.; Lawrence, Donald; Miller, David M. |
June 2021 | Immune Checkpoint Inhibition in Marjolin Ulcer: A Case Series | Journal of Immunotherapy |
|
Steffen Ventz, PhD, Leah Comment, PhD, Bill Louv, PhD, Rifaquat Rahman, MD, Patrick Y Wen, MD, Brian M Alexander, MD, Lorenzo Trippa, PhD |
June 2021 | The Use of External Control Data for Predictions and Futility Interim Analyses in Clinical Trials | Neuro-Oncology |
|
Amanda C Guidon, Leeann B Burton, Bart K Chwalisz, James M Hillis, Teilo Schaller, Kerry Lynn Reynolds, Neuro irAE Disease Definition Panel |
May 2021 | Consensus disease definitions for the spectrum of neurologic immune related adverse events | Journal of Clinical Oncology |
|
Felix D. Beacher, Lilianne R. Mujica-Parodi , Shreyash Gupta and Leonardo A. Ancora |
May 2021 | Machine Learning Predicts Outcomes of Phase III Clinical Trials for Prostate Cancer | Algorithms |
|
Ganessan Kichenadasse MBBS, FRACP, John O. Miners PhD, Arduino A. Mangoni MBBS, PhD, FRACP, Christos S. Karapetis MBBS, FRACP, Ashley M. Hopkins PhD and Michael J. Sorich PhD |
May 2021 | Proton Pump Inhibitors and Survival in Patients With Colorectal Cancer Receiving Fluoropyrimidine-Based Chemotherapy | Journal of the National Comprehensive Cancer Network |
